A recent clinical trial funded by Cancer Research UK has found that administering chemotherapy before surgery can significantly lower the risk of colon cancer recurrence. The FOxTROT trial, led by the University of Birmingham and the University of Leeds, involved 1,053 colon cancer patients from 85 hospitals across the UK, Denmark, and Sweden. The trial […]
Mi-Helper, Inc. and ObvioHealth have teamed up to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, allowing patients to use the device from the comfort of their own homes while providing essential data on a real-world population in a real-world […]
Nutritional Growth Solutions, Ltd., (NGS, ASX:NGS), a leading provider of clinically backed nutritional products designed for children, announces the launch of its clinical study to evaluate the effect of its innovative sports supplement on the physical activity performance of young soccer players. Based on extensive previous research, NGS designed its patent-pending nutritional supplement to fulfill […]
The American Journal of Translational Research has published successful results of the Phase 3 clinical trial of Coronavir (INN: favipiravir). This study aimed to evaluate the efficacy and safety of favipiravir for treatment of mild to moderate COVID-19 in outpatients and hospitalized patients. In an open-label, randomized, active-controlled clinical trial involving 168 patients with mild to moderate […]
Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the commencement of a second clinical trial in partnership with the Research & innovation Department at NHS Greater Glasgow & Clyde (NHS GG&C). The TARS trial (Toxicology Advance Respiratory System), led by Prof. David Lowe (Consultant in Emergency Medicine at the Queen Elizabeth University […]
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that its Phase II/III clinical trial to assess the efficacy and safety of its NFL-101 smoking cessation treatment has been approved by the French National Agency for the Safety of Medicines and Health Products […]
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile […]
